Elissa M. Ozanne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elissa M. Ozanne has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Kevin S. Hughes
Division of Oncologic & Endocrine Surgery, Department of Surgery, Medical University of South Carolina, Charleston, SC
2 shared publications - Adrian Edwards
School of Medicine, Cardiff University, Cardiff, UK
1 shared publication Adrienne O'Connell
Massachusetts General Hospital Boston MA USA
1 shared publicationAlan Semine
Newton‐Wellesley Hospital Newton MA USA
1 shared publication- Angela Buchholz
Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
1 shared publication Brian Drohan
Avon Breast Evaluation Center Massachusetts General Hospital Boston MA USA
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 29 November 2013
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 13 (S2) , S7
Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers
Making evidence-based decisions often requires comparison of two or more options. Research-based evidence may exist which quantifies how likely the outcomes are for each option. Understanding these numeric estimates improves patients’ risk perception and leads to better informed decision making. This paper summarises current “best practices” in communication of evidence-based numeric outcomes for developers of patient decision aids (PtDAs) and other health communication tools.
- 29 November 2013
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 13 (S2) , S7
Top Cited PapersOpen AccessPresenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers
Making evidence-based decisions often requires comparison of two or more options. Research-based evidence may exist which quantifies how likely the outcomes are for each option. Understanding these numeric estimates improves patients’ risk perception and leads to better informed decision making. This paper summarises current “best practices” in communication of evidence-based numeric outcomes for developers of patient decision aids (PtDAs) and other health communication tools.
- Open Access
- 29 November 2013
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 13 (S2) , S6
Balancing the presentation of information and options in patient decision aids: an updated review
Standards for patient decision aids require that information and options be presented in a balanced manner; this requirement is based on the argument that balanced presentation is essential to foster informed decision making. If information is presented in an incomplete/non-neutral manner, it can stimulate cognitive biases that can unduly affect individuals’ knowledge, perceptions of risks and benefits, and, ultimately, preferences. However, there is little clarity about what constitutes balance, and how it can be determined and enhanced. We conducted a literature review to examine the theoretical and empirical evidence related to balancing the presentation of information and options.
- 29 November 2013
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 13 (S2) , S6
Open AccessBalancing the presentation of information and options in patient decision aids: an updated review
Standards for patient decision aids require that information and options be presented in a balanced manner; this requirement is based on the argument that balanced presentation is essential to foster informed decision making. If information is presented in an incomplete/non-neutral manner, it can stimulate cognitive biases that can unduly affect individuals’ knowledge, perceptions of risks and benefits, and, ultimately, preferences. However, there is little clarity about what constitutes balance, and how it can be determined and enhanced. We conducted a literature review to examine the theoretical and empirical evidence related to balancing the presentation of information and options.
- Open Access
- 28 October 2013
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 173 (19) , 1830-1831
Impact of Ductal Carcinoma In Situ Terminology on Patient Treatment Preferences
Ductal carcinoma in situ (DCIS) is a preinvasive malignancy of the breast and is diagnosed in more than 50 000 women a year in the United States. It is treated with either mastectomy or lumpectomy, often combined with radiation therapy.1 In cases of low-grade DCIS, studies suggest that if progression occurs, it does so within a time frame of 5 to 40 years2 and possibly in only 20% of DCIS cases.3 This raises the possibility that some cases of DCIS will follow an indolent course that will not attain clinical significance during the patient’s lifetime. Accordingly, watchful waiting has been proposed as a reasonable option for DCIS,4 akin to what is currently offered for patients with early stage prostate cancer; however, how to implement such a strategy is unclear.
- 28 October 2013
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 173 (19) , 1830-1831
Open AccessImpact of Ductal Carcinoma In Situ Terminology on Patient Treatment Preferences
Ductal carcinoma in situ (DCIS) is a preinvasive malignancy of the breast and is diagnosed in more than 50 000 women a year in the United States. It is treated with either mastectomy or lumpectomy, often combined with radiation therapy.1 In cases of low-grade DCIS, studies suggest that if progression occurs, it does so within a time frame of 5 to 40 years2 and possibly in only 20% of DCIS cases.3 This raises the possibility that some cases of DCIS will follow an indolent course that will not attain clinical significance during the patient’s lifetime. Accordingly, watchful waiting has been proposed as a reasonable option for DCIS,4 akin to what is currently offered for patients with early stage prostate cancer; however, how to implement such a strategy is unclear.
- 12 January 2012
- Published by Wiley in Journal of Genetic Counseling
- Vol. 21 (4) , 547-556
Bias in the Reporting of Family History: Implications for Clinical Care
Family history of cancer is critical for identifying and managing patients at risk for cancer. However, the quality of family history data is dependent on the accuracy of patient self reporting. Therefore, the validity of family history reporting is crucial to the quality of clinical care. A retrospective review of family history data collected at a community hospital between 2005 and 2009 was performed in 43,257 women presenting for screening mammography. Reported numbers of breast, colon, prostate, lung, and ovarian cancer were compared in maternal relatives vs. paternal relatives and in first vs. second degree relatives. Significant reporting differences were found between maternal and paternal family history of cancer, in addition to degree of relative. The number of paternal family histories of cancer was significantly lower than that of maternal family histories of cancer. Similarly, the percentage of grandparents’ family histories of cancer was significantly lower than the percentage of parents’ family histories of cancer. This trend was found in all cancers except prostate cancer. Self‐reported family history in the community setting is often influenced by both bloodline of the cancer history and the degree of relative affected. This is evident by the underreporting of paternal family histories of cancer, and also, though to a lesser extent, by degree. These discrepancies in reporting family history of cancer imply we need to take more care in collecting accurate family histories and also in the clinical management of individuals in relation to hereditary risk.
- 12 January 2012
- Published by Wiley in Journal of Genetic Counseling
- Vol. 21 (4) , 547-556
Bias in the Reporting of Family History: Implications for Clinical Care
Family history of cancer is critical for identifying and managing patients at risk for cancer. However, the quality of family history data is dependent on the accuracy of patient self reporting. Therefore, the validity of family history reporting is crucial to the quality of clinical care. A retrospective review of family history data collected at a community hospital between 2005 and 2009 was performed in 43,257 women presenting for screening mammography. Reported numbers of breast, colon, prostate, lung, and ovarian cancer were compared in maternal relatives vs. paternal relatives and in first vs. second degree relatives. Significant reporting differences were found between maternal and paternal family history of cancer, in addition to degree of relative. The number of paternal family histories of cancer was significantly lower than that of maternal family histories of cancer. Similarly, the percentage of grandparents’ family histories of cancer was significantly lower than the percentage of parents’ family histories of cancer. This trend was found in all cancers except prostate cancer. Self‐reported family history in the community setting is often influenced by both bloodline of the cancer history and the degree of relative affected. This is evident by the underreporting of paternal family histories of cancer, and also, though to a lesser extent, by degree. These discrepancies in reporting family history of cancer imply we need to take more care in collecting accurate family histories and also in the clinical management of individuals in relation to hereditary risk.
- 20 October 2011
- Published by Taylor & Francis in Journal of Interprofessional Care
- Vol. 25 (6) , 423-427
Interprofessional practice and decision support: An organizational framework applied to a mental health setting
Decision support as a means to assist people in making healthcare decisions has been discussed extensively in the medical literature. However, the potential for use of decision support and decision aids with people with psychiatric disabilities in order to promote recovery has only begun to be researched and discussed in the mental health literature. Organizational factors that foster interprofessional practice within a decision support environment focused on mental health issues are examined in this paper.
- 20 October 2011
- Published by Taylor & Francis in Journal of Interprofessional Care
- Vol. 25 (6) , 423-427
Interprofessional practice and decision support: An organizational framework applied to a mental health setting
Decision support as a means to assist people in making healthcare decisions has been discussed extensively in the medical literature. However, the potential for use of decision support and decision aids with people with psychiatric disabilities in order to promote recovery has only begun to be researched and discussed in the mental health literature. Organizational factors that foster interprofessional practice within a decision support environment focused on mental health issues are examined in this paper.
- 31 December 2009
- Published by Elsevier in Breast Diseases: A Year Book Quarterly
- Vol. 20 (3) , 248-250
Challenges and Improvements in the Identification of Women at High Risk
- 31 December 2009
- Published by Elsevier in Breast Diseases: A Year Book Quarterly
- Vol. 20 (3) , 248-250
Challenges and Improvements in the Identification of Women at High Risk